Informations générales (source: ClinicalTrials.gov)
Optimization of a Non-invasive Electrophysiological Method for Studying the Functionality of Auditory Nerve Fibers (ECOG)
Interventional
N/A
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
avril 2019
mai 2026
29 juin 2024
Acoustic overexposure can induced temporary or hearing loss. Usually hearing loss is
associated with cochlear cell damages. Recently, a new pathological entity was described
and called "hidden hearing loss". In animal model, the histopathology revealed a
selective reduction in the number of auditory fibers, resulting in a decrease in the
amplitude of wave I of the auditory brainstem response. Electrocochleography (Ecog) is a
method for recording the electrical potentials of the cochlea (e.g. wave I). In clinical
routine, Ecog is performed invasively with sedation or local anesthesia. Actually, a non
invasive approach could be perform but it seems necessary to optimize this method and to
define reference values in healthy volunteers.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
Chu Clermont Ferrand - 63003 - Clermont-Ferrand - France | Lise Laclautre | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Between 18 and 55 years old
- be affiliated to a social security system
- understand (oral and written) of the French language
- be a qualified hearing with normal tympanogram and audiogram
- Between 18 and 55 years old
- be affiliated to a social security system
- understand (oral and written) of the French language
- be a qualified hearing with normal tympanogram and audiogram
- have a complaint of hearing
- have a exposure to noise (professional and/or activities)
- refusal to participate in the study
- have ear infections and/or ENT medical history
- have cardiovascular, metabolic, neurological and psychiatric desease
- being a protected person
- healthy volunteer who has received compensation equal to or greader than 4500€ in
clinical study